Optimization criteria for ordering myeloid neoplasm next‐generation sequencing

Optimization criteria for ordering myeloid neoplasm next‐generation sequencing

Abstract Introduction Myeloid neoplasms (MNs) frequently harbor pathogenic mutations not detected by karyotyping and fluorescence in situ hybridization; hence, next‐generation sequencing (NGS) is necessary for diagnosis, risk stratification, and therapy. If, however, NGS is not clinically indicated...

Full description

Saved in:
Bibliographic Details
Main Authors: Savanah D. Gisriel, John G. Howe, Christopher A. Tormey, Richard Torres, Karl M. Hager, Henry M. Rinder, Alexa J. Siddon
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:eJHaem
Subjects:
MDS
myeloid neoplasms
next‐generation sequencing
Online Access:https://doi.org/10.1002/jha2.1036
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/jha2.1036

Similar Items